Dexalgin 25 mg 10 tablets — Made in Germany — Free Delivery

Product description

It has anti-inflammatory, analgesic and antipyretic effects. Pain syndrome of mild and moderate intensity in acute and chronic inflammatory diseases of the musculoskeletal system; menstrual and toothache. Inside, 1 tab 1-3 r per day with an interval of 8 hours for 3-5 days. Max dose - 75 mg / day.

Structure

Core:

Active ingredient: Dexketoprofen trometamol? 36.90 mg (dexketoprofen equivalent) 25.00 mg.

Excipients: microcrystalline cellulose? 141.20 mg, corn starch? 49.60 mg, sodium carboxymethyl starch (type A)? 27.10 mg, glycerol distearate? 5.20 mg.

Film sheath: hypromellose? 1.34 mg, titanium dioxide (E 171)? 0.36 mg, macrogol 6000? 0.60 mg, propylene glycol? 0.42 mg.

Pharmachologic effect

Non-steroidal anti-inflammatory preparation. It has anti-inflammatory, analgesic and antipyretic effects. The mechanism of action of the preparation is based on the inhibition of the synthesis of prostaglandins due to the suppression of cyclooxygenase. The analgesic effect occurs 30 minutes after taking the preparation, its duration is from 4 to 6 hours.

Indications

Pain syndrome of mild and moderate intensity in the following diseases and conditions: - acute and chronic inflammatory diseases of the musculoskeletal system (rheumatoid arthritis, spondyloarthritis, arthrosis, osteochondrosis); - dysmenorrhea; - toothache.

Method of administration and dosage

Set individually. The average recommended single dose is 12.5 mg (1/2 tab.) From 1 to 6 times / day every 4-6 hours as needed or 25 mg (1 tab.) From 1 to 3 times / day every 8 hours. Maximum daily the dose is 75 mg (6 tab.). In patients with impaired liver or kidney function, in the elderly, the preparation should be taken in lower doses - no more than 50 mg / day. The preparation is not intended for long-term use: the duration of administration should not exceed 3-5 days.

Side effects

From the digestive system: heartburn, abdominal pain; rarely - erosive and ulcerative lesions of the gastrointestinal tract. From the side of the central nervous system and peripheral nervous system: headaches, dizziness, nervousness, sleep disturbance, paresthesia. From the side of the cardiovascular system: palpitations, increased blood pressure. Allergic reactions: skin rash, bronchospasm. Others: chills, swelling of the limbs, photosensitivity; rarely - a change in the picture of peripheral blood, renal dysfunction. When used according to indications and in recommended doses, the preparation is well tolerated.

Contraindications

- peptic ulcer of the stomach and duodenum; - gastrointestinal bleeding; - active bleeding of various origins; - increased bleeding; - anticoagulant therapy; - Crohn's disease; - nonspecific ulcerative colitis; - bronchial asthma (including history); - severe heart failure; - severe renal failure; - severe liver failure; - pregnancy; - lactation period; - hypersensitivity to dexketoprofen or other NSAIDs.

Overdose

Treatment: gastric lavage; if necessary, symptomatic therapy.

Special instructions

Care should be taken when prescribing the preparation to elderly patients, patients with allergic reactions, systemic diseases of the connective tissue and patients with impaired hematopoiesis. Patients should be informed that in case of side effects, as well as in the absence of a clinical effect within 3-5 days of treatment, it is necessary to inform the attending physician about it. Special care is required with the simultaneous use of Dexalgin 25 with phenytoin, sulfonamides and preparations that reduce blood clotting. Influence on the ability to drive vehicles and control mechanisms Since Dexalgin 25 can cause dizziness and drowsiness, the preparation should be prescribed with caution to patients engaged in potentially hazardous activities that require increased attention and speed of psychomotor reactions.

Interaction with other preparations

The simultaneous use of Dexalgin 25 with other NSAIDs may increase the risk of side effects. The simultaneous use of Dexalgin 25 with lithium preparations can increase the concentration of the latter in the blood plasma. Caution should be exercised when using NSAIDs less than 24 hours before the start of use or after the end of methotrexate therapy, since its level in the blood (and, therefore, toxicity) may increase. Some cases of bleeding with the simultaneous use of NSAIDs and anticoagulants are described.

Storage conditions

The preparation should be stored in a dark place, out of the reach of children, at a temperature not exceeding 30 ° C. Shelf life is 2 years.